GlassScriptPhysician profile
Jorge L Arango
NPI 1295764983
$3,357.90
in general payments reported to CMS, 2019-2025
20 companies · $822 in 2025
The $822 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $810 · 2020: $414 · 2022: $196 · 2023: $668 · 2024: $448 · 2025: $822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,936.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $493.62 | 2019-2025 | Eylea Hd, Eylea |
| Abbvie INC. | $400.45 | 2022-2025 | Ozurdex |
| Alimera Sciences, INC. | $380.94 | 2019-2024 | Yutiq, Iluvien |
| Astellas Pharma US INC | $355.14 | 2023-2025 | Izervay |
| Allergan, INC. | $307.98 | 2019-2020 | |
| Integra Lifesciences Corporation | $245.18 | 2024 | Trudi Probe, Inspira Air, Acclarent Aera |
| Genentech USA, INC. | $181.85 | 2020-2023 | Vabysmo |
| Ani Pharmaceuticals, INC. | $170.55 | 2025 | Iluvien, Purified Cortrophin Gel, Yutiq |
| Sun Pharmaceutical Industries INC. | $137.50 | 2019 | |
| Coherus Oncology, INC. | $136.92 | 2022-2023 | |
| Apellis Pharmaceuticals, INC. | $122.65 | 2023-2025 | Syfovre |
| Novartis Pharmaceuticals Corporation | $101.17 | 2019-2020 | |
| Aerin Medical INC. | $88.16 | 2025 | |
| Kala Pharmaceuticals, INC. | $87.84 | 2020 | |
| Sandoz INC. | $48.65 | 2024-2025 | Cimerli |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $32.31 | 2019 | |
| Alcon Vision LLC | $20.94 | 2025 | Rocklatan |
| Carl Zeiss Meditec USA, INC. | $17.22 | 2022 | |
| Harrow Eye, LLC | $16.06 | 2024 | Iheezo |
| Carl Zeiss Meditec, INC. | $12.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Arango listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.